ArticleMolecules (Basel, Switzerland)2018

Targeting of FGF-Signaling Re-Sensitizes Gastrointestinal Stromal Tumors (GIST) to Imatinib In Vitro and In Vivo.

Sergei Boichuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.